Showing 1 - 1 results of 1 for search 'Komal Gupte-Singh', query time: 0.02s Refine Results
  1. 1
    Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis in the United States

    Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis in the United States by Daniel Kantor, Timothy Pham, Oscar Patterson-Lomba, Elyse Swallow, Akanksha Dua, Komal Gupte-Singh

    Published 2023-03-01
    Get full text
    Article

Search Tools: